e 64 has been researched along with Trypanosomiasis, African in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bova, F; Carnovale, C; Ettari, R; Gelhaus, C; Grasso, S; Leippe, M; Micale, N; Schirmeister, T; Zappalà, M | 1 |
| Amendola, G; Chouchene, K; Cosconati, S; Ettari, R; Grasso, S; Gut, J; Hellmich, UA; Krauth-Siegel, RL; Previti, S; Rosenthal, PJ; Schirmeister, T; Schmid, I; Ulrich, K; Wagner, A; Wich, PR; Zappalà, M | 1 |
2 other study(ies) available for e 64 and Trypanosomiasis, African
| Article | Year |
|---|---|
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors.
Topics: Antiprotozoal Agents; Cysteine Endopeptidases; Humans; Malaria, Falciparum; Peptides; Plasmodium falciparum; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2010 |
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
Topics: Antimalarials; Carbamates; Cathepsin L; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dipeptides; HeLa Cells; Humans; Hydrogen Bonding; Malaria; Molecular Docking Simulation; Molecular Dynamics Simulation; Neglected Diseases; Phenylalanine; Plasmodium falciparum; Stereoisomerism; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2017 |